January 21, 2021

The Niche

Trusted stem cell blog & resources

Anne Wojcicki

1 min read

23andMe CEO, Anne Wojcicki, just emailed 23andMe customers (me included) with the big news that the FDA has approved the company to offer Bloom syndrome carrier status reporting. As Wojcicki points out, this is the first time ever that the FDA has granted authorization of a direct-to-consumer genetic test. This is a huge deal. Why Bloom syndrome? Why now? What else is coming? A lot of interesting questions. Update: Here is the FDA statement on the authorization including this key requirement: “If sold over …Read More